位置:成果数据库 > 期刊 > 期刊详情页
中西医结合治疗肉芽肿性乳腺炎的疗效及其对免疫组化指标Ki-67抗原的影响
  • ISSN号:1673-5250
  • 期刊名称:《中华妇幼临床医学杂志(电子版)》
  • 时间:0
  • 分类:R655.8[医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:[1]石家庄市第四医院,050011, [2]石家庄心脑血管病医院,050081
  • 相关基金:河北省中医药管理局科研计划项目(2015088)
中文摘要:

目的探讨口服中药康复新液联合曲安奈德局部注射治疗肉芽肿性乳腺炎的疗效,以及治疗后,对免疫组化指标Ki-67抗原的影响。方法选取2011年6月至2016年10月,于石家庄市第四医院被确诊为肉芽肿性乳腺炎的104例患者为研究对象。按照就诊顺序的奇、偶数,将其随机纳入研究组(n=50,采用口服康复新液联合曲安奈德于病灶组织局部注射方案治疗)与对照组(n=54,单纯采用曲安奈德于病灶组织局部注射治疗方案)。统计学分析2组肉芽肿性乳腺炎患者的治疗疗效,以及治疗前、后肉芽肿性乳腺炎病灶活组织病理学检查的免疫组化指标Ki-67抗原表达变化。2组患者年龄、病程、病情严重程度、生活习惯等一般临床资料比较,差异均无统计学意义(P〉0.05)。本研究遵循的程序符合病例收集医院人体试验委员会所制定的伦理学标准,得到该委员会批准,分组征得受试对象本人的知情同意,并与之签署临床研究知情同意书。结果研究组采用口服康复新液联合曲安奈德局部注射方案治疗3周后,乳房疼痛评分、局部肿块直径变化评分、局部皮肤状况评分等疗效指标,均较对照组具有显著优势,2组比较,差异均有统计学意义(t=5.033,P〈0.001;t=6.102,P〈0.001;t=4.317,P=0.003)。治疗前,2组患者肉芽肿性乳腺炎病灶免疫组化指标Ki-67抗原高表达率(Ki-67抗原阳性细胞所占百分率≥20%)与低表达率(Ki-67抗原阳性细胞所占百分率〈20%)构成比比较,差异无统计学意义(χ~2=0.388,P=0.533)。治疗3周后,研究组肉芽肿性乳腺炎病灶组织免疫组化指标Ki-67抗原低表达率为80.0%(40/50),显著高于对照组的55.6%(36/54),2组比较,差异有统计学意义(χ~2=7.050,P=0.008)。结论采取口服康复新液联合曲安奈德进行病灶组织局部注射治疗肉芽肿性乳腺炎,可有效降低炎性细胞增殖活性,提高疗效。但是,该治疗?

英文摘要:

Objective To study curative effects of oral Chinese medicine of kangfuxin solution combined with triamcinolone acetonide locally injection in treatment of local lesion in granulomatous mastitis,and its influences on the immunohistochemistry index of Ki-67 antigen after treatment.Methods From June 2011 to October 2016,a total of 104 cases of patients who were diagnosed as granulomatous mastitis and were treated in Fourth Hospital of Shijiazhuang were selected as research subjects.According to their odd and even number of doctors′office visiting,they were randomly divided into research group(n=50,treated by kangfuxin solution combined with triamcinolone acetonide locally injection),and control group(n=54,only treated by triamcinolone acetonide locally injection).Statistical methods were used to analyze the curative effects of patients with granulomatous mastitis between two groups,as well as influences on the immunohistochemistry index of Ki-67 antigen after treatment.There were no significant differences between two groups among age,course of disease,severity degree of disease and living habits(P〉0.05).The study protocol was approved by the Ethical Review Board of Investigation in Human Being of cases collection hospital.Informed consent was obtained from each participant.Results Indicators of efficacy among breast pain score,local tumor diameter change score,skin condition score in research group after treatment for 3weeks by kangfuxin solution combined with triamcinolone acetonide locally injection all were significantly better than those in control group after treatment for 3weeks only by triamcinolone acetonide locally injection,and all the differences were statistically significant(t=5.033,P〈0.001;t=6.102,P〈0.001;t=4.317,P=0.003).Before treatment,there was no statistical difference between two groups in the constitute ratio of high and low expression rate of Ki-67(percentage of Ki-67 antigen positive cells≥20% and〈 20%)in granulomatous mastitis lesions(χ~2=0.388,P=0.533).A

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华妇幼临床医学杂志(电子版)》
  • 中国科技核心期刊
  • 主管单位:中华人民共和国卫生和计划生育委员会
  • 主办单位:中华医学会
  • 主编:
  • 地址:成都市人民南路三段20号
  • 邮编:610041
  • 邮箱:zhfyzz@163.com
  • 电话:028-85422991
  • 国际标准刊号:ISSN:1673-5250
  • 国内统一刊号:ISSN:11-9273/R
  • 邮发代号:62-322
  • 获奖情况:
  • 2006年被纳入《“十一五”国家重点电子出版物出版...,2007和2010年被中国科技论文统计源期刊(中国科技...,2010年被世界六大检索期刊之一的美国《化学文摘》...
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,中国中国科技核心期刊
  • 被引量:7712